Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXAGEN INC. Director's Dealing 2025

Feb 25, 2025

33644_dirs_2025-02-25_75d5a4ca-9ee0-4047-b59b-3d5109c93e97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2024-11-14

Reporting Person: ABALLI JOHN (Director, President and CEO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 625093 Direct
Common Stock 40401 Indirect

Footnotes

F1: On November 18, 2024, the reporting person filed a Form 4 which inadvertently reported that, following his purchase of 24,305 shares of common stock, he directly owned 689,799 shares of common stock. In fact, as reported in this amendment, the reporting person directly owned 625,093 shares of common stock and indirectly owned 40,401 shares of common stock.